Resveratrol inhibition of lipid peroxidation

Free Radical Research

Volumn 33, Issue 1, 2000, Pages 105-114

  Tadolini, Bruna ^a   Juliano, Claudia ^b   Piu, Luisella ^b   Franconi, Flavia ^b   Cabrini, Luciana ^b  

^a NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

^b NONE

Author keywords

AAPH; AMVN; Iron; Lipid peroxidation; Phosphatidylcholine liposomes; Resveratrol

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; 2,2' AZOBIS(2 AMIDINOPROPANE); 2,2' AZOBIS(2,4 DIMETHYLVALERONITRILE); ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; FERRIC ION; FERROUS ION; LIPID HYDROPEROXIDE; LIPOSOME; OXYGEN; PEROXY RADICAL; PHOSPHATIDYLCHOLINE; RESVERATROL; TROLOX C;

ARTICLE; CATALYST; CONTROLLED STUDY; LIPID PEROXIDATION; MOLECULAR DYNAMICS; OXIDATION; OXYGEN CONSUMPTION; REDUCTION;

EID: 0034042402     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/10715760000300661     Document Type: Article

References (41)

1. P. Langcake and R.J. Pryce (1976) The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection and injury. Physiology and Plant Pathology 9, 77-86.
2. M.V. Clement, J.L. Hirpara, S.H. Chawdhury and S. Pervaiz (1998) Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92, 996-1002.
3. C. Huang, W.Y. Ma, A. Goranson and Z. Dong (1999) Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis 20, 237-242.
4. F. Della Ragione, V. Cucciolla, A. Borriello, V. Della Pietra, L. Racioppi, G. Soldati, C. Manna, P. Galletti and V. Zappia (1998) Resveratrol arrests the cell division cycle at S/G2 phase transition. Biochemical and Biophysical Research Communications 250, 53-58.
5. K. Subbaramaiah, W.J. Chung, P. Michaluart, N. Telang, T. Tanabe, H. Inoue, M. Jang, J.M. Pezzuto and A.J. Dannenberg (1998) Resveratrol inhibits cyclooxygenase-2-transcription and activity in phorbol ester-treated human mammary epithelial cells. Journal of Biological Chemistry 273, 21 875-21 882.
6. Y. Kimura, H. Okuda and M. Kubo (1995) Effects of stilbenes isolated from medicinal plants on arachidonate metabolism and degranulation in human polymorphonuclear leukocytes. Journal of Ethnopharmacology 45, 131-139.
7. C.R. Pace-Asciak, S. Haln, E.P. Diamandis, G. Soleas and D.M. Goldberg (1995) The red wine phenolics transresveratrol and quercitin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clinica Chimica Acta 235, 207-219.
8. M. Jang, I., Cai, G.O. Udeani, K.V. Slowing, C.F. Thomas, C.W. Beecher, H.H. Fong, N.R. Farnsworth, A.D. Kinghorn, R.G. Mehta, R.C. Moon and J.M. Pezzuto (1997) Cancer chemoprotective activity of resveratrol, a natural product derived from grapes. Science 275, 218-220.
9. D.S. Jang, B.S. Kang, S.Y. Ryu, I.M. Chang, K.R. Min and Y. Kim (1999) Inhibitory effects ot resveratrol analogs on unopsonized zymosan-induced oxygen radical production. Biochemical Pharmacology 57, 705-712.
10. M.I. Cluing, C.M. Teng, K.L. Cheng, F.N. Ko and C.N. Lin (1992) An antiplatelet principle of Veratrum formosarum. Planta Madica 58, 274-276.
11. E.H. Siemann and L.L. Creasy (1492) Concentration ot the phytoalexin resveratrol in wine. American Journal of Enology and Viticulture 43, 49-52.
12. E.N. Frankel, J. Kanner, J.B. German, E. Parks and J.E. Kinsella (1993) Inhibition of oxidation of human-low density lipoprotein by phenolic substances in red wine. Lancet 341, 454-457.
13. E.N. Frankel, A.L. Waterhouse and J.E. Kinsella (1993) Inhibition of human LDL oxidation by resveratrol. Lancet 341, 1103-1104.
14. J. Constant (1997) Alcohol, ischemic heart disease, and the French paradox. Coronary Artery Disease 8, 645-649.
15. L. Belguendouz, L. Fremont and A. Linard (1997) Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins. Biochemical Pharmacology 53, 1347-1355.
16. L. Belguendouz, L. Fremont and M.T. Gozzelino (1998) Interaction of transresveratrol with plasma lipoproteins. Biochemical Pharmacology 55, 811-816.
17. T. Wilson, T.J. Knight, D.C Beitz, D.S. Lewis and R.L. Engen (1996) Resveratrol promotes atherosclerosis in hypercholesterolemic rabbits. Life Sciences 59, 15-21.
18. J.F. Turrens, J. Lariccia and M.G. Nair (1997) Resveratrol has no effect on lipoprotein profile and does not prevent peroxidation of serum lipids in normal rats. Free Radical Research 27, 557-562.
19. K.K. Griendling and M. Ushio-Fukai (1998) Redox control of vascular smooth muscle proliferation. Journal of Laboratory and Clinical Medicine 132, 9-15.
20. M.B. Hampton and S. Orrenius (1998) Redox regulation of apoptosis cell death in the immune system. Toxicology Letters 102-103, 355-358.
21. D.R. Green and J.C. Reed (1998) Mitochondria and apoptosis. Science 281, 1309-1312.
22. B. Tadolini, D. Fiorentini, L. Landi and L. Cabrini (1989) Lipid peroxidation. Definition of experimental conditions for selective study of the propagation and termination phases. Free Radical Research Communications 5, 245-252.
23. B. Tadolini and G. Hakim (1996) The mechanism of iron(III) stimulation of lipid peroxidation. Free Radical Research 25, 221-227.
24. B. Tadolini, L. Cabrini, C. Menna, G.G. Pinna and G. Hakim (1997) Iron(III) stimulation of lipid hydroperoxide-dependent lipid peroxidation. Free Radical Research 27, 563-576.
25. M.J. Hope, M.B. Bally, G. Webb and P.R. Cullis (1985) Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potential. Biochimica and Biophysica Acta 812, 55-65.
26. L. Landi, D. Fiorentini, C. Stefanelli, P. Pasquali and G.F. Pedulli (1990) Inhibition of autoxidation of egg yolk phosphatidylcholine in homogeneous solution and in liposomes by oxidized ubiquinone. Biochimica and Biophysica Acta 1028, 223-228.
27. G. V. Marinetti (1962) Chromatographic separation, identification and analysis of phosphatides. Journal of Lipid Research 3, 1-20.
28. H.R. Mahler and D.G. Elowe (1954) Studies on metalloflavoproteins. II The role of iron in diphosphopyridine nucleotide cytochrome c reductase. Journal of Biological Chemistry 210, 165-179.
29. R.A. Klein (1970) The detection of oxidation in liposome preparations. Biochimica and Biophysica Acta 210, 468-489.
30. M. Joyeux, A. Lobstein, R. Anton and F. Mortier (1995) Comparative antilipoperoxidant, antinecrotic and scavenging properties of terpenes and biflavones from Ginko and some flavonoids. Planta Medica 61, 126-129.
31. W. Brand-Williams, M.E. Cuvelier and C. Berset (1995) Use of a free radical method to evaluate antioxidant activity. Lebensmittel Wissenschaft und Technologie 28, 25-30.
32. 2+ concentration in switching the reaction from acceleration todecay. Free Radical Biology and Medicine 15, 239-247.
33. G. Minotti and S.D. Aust (1987) The requirement of iron(III) in the initiation of lipid peroxidation by iron(II) and hydrogen peroxide. Journal of Biological Chemistry 262, 1098-1104.
34. G. Minotti and S.D. Aust (1992) Redox cycling of iron and lipid peroxidation. Lipids 27, 219-226.
35. B. Tadolini and F. Franconi (1998) Carvedilol inhibition of lipid peroxidation. A new antioxidative mechanism. Free Radical Research 29, 377-387.
36. R.T. Dean, J.V. Hunt, A.J. Grant, Y. Yamamoto and E. Niki (1991) Free radical damage to proteins: the influence of the relative localization of radical generation, antioxidants, and target proteins. Free Radical Biology and Medicine 11, 161-168.
37. J.R. Wardlaw, W.H. Sawyer and K.P. Ghiggino (1987) Vertical fluctuations of phospholipid acyl chains in bilayers. FEBS Letters 223, 20-24.
38. A.A.E. Bertelli, L. Giovannini, R. Stradi, A. Bertelli and J.P. Tillement (1996) Plasma, urine and tissue levels of trans-and cis-resveratrol (3,4′,5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats. International Journal of Tissue Reactivity 18, 67-71.
39. K. Engelhart, A.M. Jentzsch, P. Fürst and H.K. Biesalski (1998) Short-term parenteral application of alpha-tocopherol leads to increased concentration in plasma and tissues of the rat. Free Radical Research 29, 421-426.
40. P.M. Farrell (1980) Deficiency states, pharmacological effects and nutrient requirements. In "Vitamin E. A Comprehensive Treatise" (Machlin, L.J. Ed.) M. Dekker Inc., New York and Basel, pp. 520-620.
41. D.J. Rader and H.B. Brewer Jr. (1993) Abetalipoproteinemia. New insights into lipoprotein assembly and vitamin E metabolism from a rare genetic disease. Journal of American Medical Association 270, 865-869.